PT20: Completed Phase IIb enrollment

Phosphate Therapeutics completed enrollment of about 150 patients with dialysis-dependent chronic kidney disease (CKD) in the double-blind, placebo-controlled, U.S. Phase IIb PEACH trial evaluating 40...